Literature DB >> 21865779

Albumin loss under the use of the high-performance membrane.

Kenji Tsuchida, Jun Minakuchi.   

Abstract

Beta-2-microglobulin (β(2)M) clearance has been improved in recent dialysis membranes and minimum albumin leakage has been achieved in most membranes today since dialysis membranes are now classified by β(2)M clearance in terms of the reimbursement by health insurance. Kawanishi et al. suggested that 'the desirable albumin leakage in one treatment is less than 4 g '. Function classification type IV or type V dialysis membranes have leakages as low as 3 g, while most resulted in < 1 g leakage. However, some high-performance membranes (HPMs) have around 8 g of leakage, which requires further study of the clinical efficacy using such dialysis membranes. The comparison of albumin leakage in one dialysis treatment (4 h: blood flow volume of 250 ml/min) revealed that PES-210D has an overwhelmingly high albumin leakage of 7.69 ± 1.01 g. The data were without any significant difference between the PES-D membrane user group and the non-PES-D membrane user group for hemoglobin, hematocrit, β(2)M protein, catabolic rate, body mass index, and muscle mass. However, the PES-D membrane user group had a significantly lower number of hospitalizations and other complication events. When comparing the event contents, the PES-D membrane user group had no cardiac failure and lower DRA, however it had more vascular access problems. In normal renal function, approximately 10 g of albumin is filtered in the glomerulus per day, decomposed in the renal tubule and reabsorbed as amino acid, and re-synthesized into albumin in the liver. On the contrary, in dialysis patients, albumin that is bound to biologically active substances and/or the oxidized form of albumin that has lost its antioxidant effect cannot be filtered from the kidney and accumulate. Therefore, the idea regarding albumin leakage is to remove biologically active substances that bind to albumin and function as uremic toxin, remove albumin without the antioxidant effect, and facilitate synthesis of new albumin with an antioxidant effect.
Copyright © 2011 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21865779     DOI: 10.1159/000328957

Source DB:  PubMed          Journal:  Contrib Nephrol        ISSN: 0302-5144            Impact factor:   1.580


  11 in total

Review 1.  The Diet and Haemodialysis Dyad: Three Eras, Four Open Questions and Four Paradoxes. A Narrative Review, Towards a Personalized, Patient-Centered Approach.

Authors:  Giorgina Barbara Piccoli; Maria Rita Moio; Antioco Fois; Andreea Sofronie; Lurlinys Gendrot; Gianfranca Cabiddu; Claudia D'Alessandro; Adamasco Cupisti
Journal:  Nutrients       Date:  2017-04-10       Impact factor: 5.717

2.  Medium cut-off membranes - closer to the natural kidney removal function.

Authors:  Carina Zweigart; Adriana Boschetti-de-Fierro; Michael Hulko; Lars-Göran Nilsson; Werner Beck; Markus Storr; Bernd Krause
Journal:  Int J Artif Organs       Date:  2017-05-26       Impact factor: 1.595

Review 3.  Slipping Through the Pores: Hypoalbuminemia and Albumin Loss During Hemodialysis.

Authors:  Kamyar Kalantar-Zadeh; Linda H Ficociello; Jennifer Bazzanella; Claudy Mullon; Michael S Anger
Journal:  Int J Nephrol Renovasc Dis       Date:  2021-01-20

4.  Super high-flux membrane dialyzers improve mortality in patients on hemodialysis: a 3-year nationwide cohort study.

Authors:  Masanori Abe; Ikuto Masakane; Atsushi Wada; Shigeru Nakai; Kosaku Nitta; Hidetomo Nakamoto
Journal:  Clin Kidney J       Date:  2021-09-28

5.  Serum Soluble (Pro)Renin Receptor Levels in Maintenance Hemodialysis Patients.

Authors:  Yoshifumi Amari; Satoshi Morimoto; Fumitaka Nakajima; Takashi Ando; Atsuhiro Ichihara
Journal:  PLoS One       Date:  2016-07-01       Impact factor: 3.240

Review 6.  Current approaches to middle molecule removal: room for innovation.

Authors:  Ikuto Masakane; Kenji Sakurai
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

Review 7.  Membrane innovation: closer to native kidneys.

Authors:  Markus Storr; Richard A Ward
Journal:  Nephrol Dial Transplant       Date:  2018-10-01       Impact factor: 5.992

8.  Prescribing Hemodialysis or Hemodiafiltration: When One Size Does Not Fit All the Proposal of a Personalized Approach Based on Comorbidity and Nutritional Status.

Authors:  Giorgina Barbara Piccoli; Louise Nielsen; Lurilyn Gendrot; Antioco Fois; Emanuela Cataldo; Gianfranca Cabiddu
Journal:  J Clin Med       Date:  2018-10-08       Impact factor: 4.241

9.  Albumin losses during hemodiafiltration: all dialyzers are not created equal - a case report.

Authors:  Charles Cuvelier; Michel Tintillier; Gabriela Migali; Charlotte Van Ende; Jean-Michel Pochet
Journal:  BMC Nephrol       Date:  2019-10-28       Impact factor: 2.388

10.  Evaluation of the efficacy of a medium cut-off dialyser and comparison with other high-flux dialysers in conventional haemodialysis and online haemodiafiltration.

Authors:  Ana García-Prieto; Almudena Vega; Tania Linares; Soraya Abad; Nicolás Macías; Inés Aragoncillo; Esther Torres; Andrés Hernández; Diego Barbieri; José Luño
Journal:  Clin Kidney J       Date:  2018-02-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.